These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1134 related items for PubMed ID: 24815103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M.
    J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R, Deo V.
    Int J Periodontics Restorative Dent; 2013 Sep; 33(2):e58-64. PubMed ID: 23484181
    [Abstract] [Full Text] [Related]

  • 10. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M, Femminella B, Coppolino E, Sammartino G, D'Arcangelo C, Perfetti G, Perinetti G.
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [Abstract] [Full Text] [Related]

  • 11. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A, Schwarz F, Chiantella GC, Donos N, Arweiler NB, Brecx M, Becker J.
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [Abstract] [Full Text] [Related]

  • 12. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
    Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E.
    J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
    [Abstract] [Full Text] [Related]

  • 13. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G, Bernardi F, Montebugnoli L, De SM.
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [Abstract] [Full Text] [Related]

  • 14. Clinical and radiographic evaluation of regenerative potential of GTR membrane (Biomesh®) along with alloplastic bone graft (Biograft®) in the treatment of periodontal intrabony defects.
    Mopur JM, Devi TR, Ali SM, Srinivasa TS, Gopinath V, Salam AR.
    J Contemp Dent Pract; 2013 May 01; 14(3):434-9. PubMed ID: 24171985
    [Abstract] [Full Text] [Related]

  • 15. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M, Tonetti MS, Zabalegui I, Sicilia A, Blanco J, Rebelo H, Rasperini G, Merli M, Cortellini P, Suvan JE.
    J Periodontol; 2004 May 01; 75(5):726-33. PubMed ID: 15212355
    [Abstract] [Full Text] [Related]

  • 16. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F, Arweiler N, Húszár T, Gera I, Miron RJ, Sculean A.
    J Periodontol; 2013 Nov 01; 84(11):1546-55. PubMed ID: 23327604
    [Abstract] [Full Text] [Related]

  • 17. Clinical guidelines of the Italian Society of Periodontology for the reconstructive surgical treatment of angular bony defects in periodontal patients.
    Pagliaro U, Nieri M, Rotundo R, Cairo F, Carnevale G, Esposito M, Cortellini P, Pini-Prato G, Italian Society of Periodontology.
    J Periodontol; 2008 Dec 01; 79(12):2219-32. PubMed ID: 19053910
    [Abstract] [Full Text] [Related]

  • 18. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
    Lekovic V, Camargo PM, Weinlaender M, Kenney EB, Vasilic N.
    J Periodontol; 2001 May 01; 72(5):583-9. PubMed ID: 11394392
    [Abstract] [Full Text] [Related]

  • 19. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm PM, Meiss C, Eickholz P, Jepsen S.
    J Clin Periodontol; 2011 Jul 01; 38(7):652-60. PubMed ID: 21564156
    [Abstract] [Full Text] [Related]

  • 20. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F, Arweiler NB, Szántó E, Agics A, Gera I, Sculean A.
    J Periodontol; 2013 Jun 01; 84(6):749-57. PubMed ID: 22873657
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.